Table of Contents
ISRN Endocrinology
Volume 2012 (2012), Article ID 384707, 8 pages
http://dx.doi.org/10.5402/2012/384707
Research Article

Sociodemographic Predictors of Survival in Differentiated Thyroid Cancer: Results from the SEER Database

1Department of Surgery, University of California San Diego, San Diego, CA 92103, USA
2Department of Surgery, Moores UCSD Cancer Center, 3855 Health Science Drive 0987, La Jolla, CA 92093-0987, USA

Received 9 March 2012; Accepted 26 June 2012

Academic Editors: C. Anderwald, R. V. García-Mayor, S. La Rosa, and Y. Tajiri

Copyright © 2012 Lily E. Johnston et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. A. Kilfoy, T. Zheng, T. R. Holford et al., “International patterns and trends in thyroid cancer incidence, 1973–2002,” Cancer Causes and Control, vol. 20, no. 5, pp. 525–531, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Y. Chen, A. Jemal, and E. M. Ward, “Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005,” Cancer, vol. 115, no. 16, pp. 3801–3807, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Davies and H. G. Welch, “Increasing incidence of thyroid cancer in the United States, 1973–2002,” Journal of the American Medical Association, vol. 295, no. 18, pp. 2164–2167, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. N. C. Hodgson, J. Button, and C. C. Solorzano, “Thyroid cancer: is the incidence still increasing?” Annals of Surgical Oncology, vol. 11, no. 12, pp. 1093–1097, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. S. D. Larson, L. N. Jackson, T. S. Riall et al., “Increased incidence of well-differentiated thyroid cancer associated with hashimoto thyroiditis and the role of the PI3k/Akt pathway,” Journal of the American College of Surgeons, vol. 204, no. 5, pp. 764–775, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Tubiana, M. Schlumberger, and P. Rougier, “Long-term results and prognostic factors in patients with differentiated thyroid carcinoma,” Cancer, vol. 55, no. 4, pp. 794–804, 1985. View at Google Scholar · View at Scopus
  7. L. A. Akslen, A. O. Myking, H. Salvesen, and J. E. Varhaug, “Prognostic importance of various clinicopathological features in papillary thyroid carcinoma,” European Journal of Cancer Part A, vol. 29, no. 1, pp. 44–51, 1993. View at Google Scholar · View at Scopus
  8. Z. W. Baloch and V. A. LiVolsi, “Prognostic factors in well-differentiated follicular-derived carcinoma and medullary thyroid carcinoma,” Thyroid, vol. 11, no. 7, pp. 637–645, 2001. View at Google Scholar · View at Scopus
  9. M. P. Cunningham, R. B. Duda, W. Recant, J. S. Chmiel, J. Sylvester, and A. Fremgen, “Survival discriminants for differentiated thyroid cancer,” The American Journal of Surgery, vol. 160, no. 4, pp. 344–347, 1990. View at Google Scholar · View at Scopus
  10. D. S. Dean and I. D. Hay, “Prognostic indicators in differentiated thyroid carcinoma,” Cancer Control, vol. 7, no. 3, pp. 229–239, 2000. View at Google Scholar · View at Scopus
  11. F. Y. Ghori, D. R. Gutterman-Litofsky, A. Jamal, S. C. J. Yeung, R. Arem, and S. I. Sherman, “Socioeconomic factors and the presentation, management, and outcome of patients with differentiated thyroid carcinoma,” Thyroid, vol. 12, no. 11, pp. 1009–1016, 2002. View at Google Scholar · View at Scopus
  12. F. D. Gilliland, W. C. Hunt, D. M. Morris, and C. R. Key, “Prognostic factors for thyroid carcinoma. A population-based study of 15, 698 cases from the Surveillance, epidemiology and end results (SEER) program 1973–1991,” Cancer, vol. 79, no. 3, pp. 564–573, 1997. View at Google Scholar
  13. D. J. Kerr, A. D. Burt, and P. Boyle, “Prognostic factors in thyroid tumours,” British Journal of Cancer, vol. 54, no. 3, pp. 475–482, 1986. View at Google Scholar · View at Scopus
  14. S. F. Kou, T. C. Chao, C. Hsueh, W. Y. Chuang, C. H. Yang, and J. D. Lin, “Prognosis and risk stratification in young papillary thyroid carcinoma patients,” Endocrine Journal, vol. 55, no. 2, pp. 269–275, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. I. Mitchell, E. H. Livingston, A. Y. Chang et al., “Trends in thyroid cancer demographics and surgical therapy in the United States,” Surgery, vol. 142, no. 6, pp. 823–828e1, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. A. R. Shaha, “Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer,” Laryngoscope, vol. 114, no. 3, pp. 393–402, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Siironen, J. Louhimo, S. Nordling et al., “Prognostic factors in papillary thyroid cancer: an evaluation of 601 consecutive patients,” Tumor Biology, vol. 26, no. 2, pp. 57–64, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. J. A. Sipos and E. L. Mazzaferri, “Thyroid cancer epidemiology and prognostic variables,” Clinical Oncology, vol. 22, no. 6, pp. 395–404, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. S. O. Thoresen, L. A. Akslen, E. Glattre, T. Haldorsen, E. V. Lund, and M. Schoultz, “Survival and prognostic factors in differentiated thyroid cancer. A multivariate analysis of 1,055 cases,” British Journal of Cancer, vol. 59, no. 2, pp. 231–235, 1989. View at Google Scholar · View at Scopus
  20. R. Sciuto, L. Romano, S. Rea, F. Marandino, I. Sperduti, and C. L. Maini, “Natural history and clinical outcome of differentiated thyroid carcinoma: a retrospective analysis of 1503 patients treated at a single institution,” Annals of Oncology, vol. 20, no. 10, pp. 1728–1735, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Machens, S. Hauptmann, and H. Dralle, “Disparities between male and female patients with thyroid cancers: sex difference or gender divide?” Clinical Endocrinology, vol. 65, no. 4, pp. 500–505, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. M. B. Cook, S. M. Dawsey, N. D. Freedman et al., “Sex disparities in cancer incidence by period and age,” Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 4, pp. 1174–1182, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. L. G. T. Morris, A. G. Sikora, D. Myssiorek, and M. D. DeLacure, “The basis of racial differences in the incidence of thyroid cancer,” Annals of Surgical Oncology, vol. 15, no. 4, pp. 1169–1176, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. S. R. Brown, S. Lee, T. A. Brown, and B. E. Waddell, “Effect of race on thyroid cancer care in an equal access healthcare system,” American Journal of Surgery, vol. 199, no. 5, pp. 685–689, 2010. View at Publisher · View at Google Scholar · View at Scopus